Synnerva Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Synnerva General Information
Description
Developer of central nervous system drug composition designed to increase CNS efficacy and reduce side effects. The company's composition uses a method based on a combination of generic, FDA approved API's with stimulators of vagal afferents to produce low or sub-therapeutic doses, enabling patients and medical practitioners to significantly reduce the effective doses and eliminate neurological side effects.
Contact Information
Website
www.synnerva.comCorporate Office
- Rehov Wadi El Haj 13
- Nazareth 1603100
- Israel
Corporate Office
- Rehov Wadi El Haj 13
- Nazareth 1603100
- Israel
Synnerva Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Oct-2020 | Completed | Out of Business | |||
| 1. Early Stage VC | 01-Apr-2020 | Completed | Startup |
Synnerva Patents
Synnerva Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3562477-A1 | Methods and compositions for potentiating cns drugs and reducing their side effects | Inactive | 29-Dec-2016 | ||
| EP-3562477-A4 | Methods and compositions for potentiating cns drugs and reducing their side effects | Inactive | 29-Dec-2016 | ||
| US-20200188388-A1 | Methods and compositions for potentiating cns drugs and reducing their side effects | Inactive | 29-Dec-2016 | ||
| EP-3558378-A1 | Low dose drug combinations for use in preventing and treating neuronal damage | Inactive | 22-Dec-2016 | ||
| EP-3558378-A4 | Low dose drug combinations for use in preventing and treating neuronal damage | Inactive | 22-Dec-2016 | A61K31/133 |
Synnerva FAQs
-
When was Synnerva founded?
Synnerva was founded in 2019.
-
Where is Synnerva headquartered?
Synnerva is headquartered in Nazareth, Israel.
-
What industry is Synnerva in?
Synnerva’s primary industry is Drug Discovery.
-
Is Synnerva a private or public company?
Synnerva is a Private company.
-
What is Synnerva’s current revenue?
The current revenue for Synnerva is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process